✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

HUTCHMED (China) Ltd

Common Name
HUTCHMED (China)
Country
Hong Kong
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,780
Ticker
13
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the...

HUTCHMED (China)'s GHG Emissions Data Preview

In 2024, HUTCHMED (China) completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

HUTCHMED (China) has also provided a category-level breakdown for 6 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
a
0000000
Total Scope 3
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
Limited Data Preview
You are viewing a limited preview of HUTCHMED (China)’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2021, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=13&reporting_period=2024"

Verified Sources Behind HUTCHMED (China)’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore HUTCHMED (China)’s data sources below and access millions more through our Disclosure Search.

a. HUTCHMED (China)'s Sustainability Report 2024
b. HUTCHMED (China)'s Sustainability Report 2023

Insights into HUTCHMED (China)'s Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of HUTCHMED (China) amounted to 16,317 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of HUTCHMED (China) increased by 134.44%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

HUTCHMED (China)'s Scope 1 Emissions Over Time

202120222023202408001.6 k2.4 k3.2 ktCO2e-22%+31%+863%
  • Total Scope 1
  • Year-over-Year Change

What are HUTCHMED (China)'s Scope 1 emissions?

In 2024, the total Scope 1 emissions of HUTCHMED (China) were 3,083 metric tons of CO₂ equivalent (tCO₂e).a

Has HUTCHMED (China) reduced its Scope 1 emissions over time?

Since 2021, HUTCHMED (China)'s Scope 1 emissions have increased by 884.98%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2023), HUTCHMED (China)'s Scope 1 emissions increased by 863.44%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are HUTCHMED (China)'s Scope 2 emissions?

In 2024, HUTCHMED (China) reported Scope 2 greenhouse gas (GHG) emissions of 13,234 tCO₂e without specifying the calculation method.a

Has HUTCHMED (China) reduced its Scope 2 emissions over time?

Since 2021, HUTCHMED (China)'s Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 67.52%, reflecting a rising long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2023), HUTCHMED (China)'s Scope 2 emissions (Unspecified Calculation Method) rose by 99.31% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does HUTCHMED (China) use for Scope 2 reporting?

In 2024, HUTCHMED (China) reported its Scope 2 emissions using an unspecified methodology.a

HUTCHMED (China)'s Scope 2 Emissions Over Time

202120222023202403.5 k7 k10.5 k14 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into HUTCHMED (China)'s Value Chain Emissions

In 2024, HUTCHMED (China) reported 104,710 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of HUTCHMED (China) includes a breakdown across 6 of the 15 Scope 3 categories defined by the GHG Protocol, up from 1 in 2023, reflecting improved emissions accounting practices and greater transparency across the company's value chaina

HUTCHMED (China)'s Scope 3 Emissions Over Time

2021202220232024030 k60 k90 k120 ktCO2e-27%+18676%+46%
  • Total Scope 3
  • Year-over-Year Change

What are HUTCHMED (China)'s Scope 3 emissions?

In 2024, HUTCHMED (China) reported total Scope 3 emissions of 104,710 metric tons of CO₂ equivalent (tCO₂e).a

Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.a

Has HUTCHMED (China) reduced its Scope 3 emissions over time?

Since 2021, HUTCHMED (China)'s Scope 3 emissions have increased by 19,959.39%, reflecting a rising long-term trend in Scope 3 emissions over time.ab

Compared to the previous year (2023), HUTCHMED (China)'s Scope 3 emissions increased by 45.99%, suggesting that the company faced challenges in reducing emissions across its value chain.a

What categories of Scope 3 emissions does HUTCHMED (China) disclose?

In 2024, HUTCHMED (China) reported emissions for 6 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of HUTCHMED (China)'s Scope 3 emissions?

In 2024, the largest contributors to HUTCHMED (China)'s Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 77,886 tCO₂e (75.68%)
  • Capital Goods (Cat. 2): 12,148 tCO₂e (11.8%)
  • Upstream Leased Assets (Cat. 8): 3,874.27 tCO₂e (3.76%)

HUTCHMED (China)'s Scope 3 Emissions by Categories

Purchased Goods andServices (Cat. 1)(75.7%)Upstream LeasedAssets (Cat. 8)(3.8%)Capital Goods(Cat. 2)(11.8%)

Insights into HUTCHMED (China)’s GHG Emissions Intensity Compared to Industry Peers

In 2024, HUTCHMED (China) reported Scope 1 greenhouse gas (GHG) emissions of 3,083 tCO₂e and total revenues of USD 4,926 millions. This translates into an emissions intensity of 0.63 tCO₂e per millions USD.a

HUTCHMED (China)'s Scope 1 Emissions Intensity Compared to Peers

501,00020,000200,0005,000,000Scope 1 Emissions (tCO2e)505002,00020,000100,000Revenues (Millions of USD)CUPCSECCCR PharmaYear: 2024Scope 1: 175,023 tCO2eRevenue: $M 38,435Scope 1 Intensity: 4.55 tCO2e/$MIOLCPYear: 2025Scope 1: 45,920 tCO2eRevenue: $M 242Scope 1 Intensity: 189.70 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MUUUnited LaboratoriesYear: 2024Scope 1: 1,528,572 tCO2eRevenue: $M 2,084Scope 1 Intensity: 733.62 tCO2e/$MMega LifesciencesYear: 2023Scope 1: 1,809 tCO2eRevenue: $M 455Scope 1 Intensity: 3.97 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MTong Ren TangYear: 2023Scope 1: 116 tCO2eRevenue: $M 195Scope 1 Intensity: 0.59 tCO2e/$MWockhardtYear: 2025Scope 1: 11,404 tCO2eRevenue: $M 341Scope 1 Intensity: 33.43 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MLaboratorios Farmaceuticos ROVIYear: 2024Scope 1: 9,566 tCO2eRevenue: $M 795Scope 1 Intensity: 12.04 tCO2e/$MYuhanYear: 2024Scope 1: 7,059 tCO2eRevenue: $M 1,409Scope 1 Intensity: 5.01 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MCCChina TCMYear: 2024Scope 1: 104,425 tCO2eRevenue: $M 2,474Scope 1 Intensity: 42.21 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MHanmi PharmYear: 2024Scope 1: 13,515 tCO2eRevenue: $M 1,019Scope 1 Intensity: 13.26 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$MFaes FarmaYear: 2024Scope 1: 5,016 tCO2eRevenue: $M 514Scope 1 Intensity: 9.76 tCO2e/$MKaken PharmaceuticalYear: 2023Scope 1: 11,069 tCO2eRevenue: $M 548Scope 1 Intensity: 20.20 tCO2e/$MEEEris LifesciencesYear: 2025Scope 1: 1,083 tCO2eRevenue: $M 337Scope 1 Intensity: 3.21 tCO2e/$MChina Medical System HoldingsYear: 2023Scope 1: 1,628 tCO2eRevenue: $M 1,233Scope 1 Intensity: 1.32 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MHyperaYear: 2023Scope 1: 28,386 tCO2eRevenue: $M 1,632Scope 1 Intensity: 17.40 tCO2e/$MHUTCHMED (China)Year: 2024Scope 1: 3,083 tCO2eRevenue: $M 4,926Scope 1 Intensity: 0.63 tCO2e/$M

How does HUTCHMED (China)'s GHG emissions intensity compare to its peers?

In 2024, HUTCHMED (China) reported a Scope 1 emissions intensity of 0.63 tCO₂e per millions USD. Compared to the peer group median of 18.58, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does HUTCHMED (China) rank on GHG emissions intensity within its industry?

In 2024, HUTCHMED (China) ranked 2 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places HUTCHMED (China) among the top performers, with one of the lowest emissions intensities relative to peers.a

Insights into HUTCHMED (China)'s Total Carbon Footprint

In 2024, HUTCHMED (China) reported a total carbon footprint of 121,027 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 53.81% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a

The largest contributor to HUTCHMED (China)'s total carbon footprint was Scope 3 emissions, accounting for 86.52% of the company's total carbon footprint, followed by Scope 2 emissions at 10.93%.a

Want Full Access to HUTCHMED (China)'s GHG Emissions Dataset?
Start 30-Day Free Trial